Cost-effectiveness analysis
| Control | Telemedicine | Difference | ||||
|---|---|---|---|---|---|---|
| Mean (SD) | 95% CI | Mean (SD) | 95% CI | Mean (SD) | 95% CI | |
| Cost (€) | 180.4 (17.01) | (151.3 to 218.0) | 168.4 (19.65) | (135.6 to 212.8) | −11.99 (25.98) | (−62.33 to 40.99) |
| SAHS-related cost (€) | 150.9 (13.14) | (128.1 to 180.1) | 114.5 (12.08) | (94.13 to 141.5) | −36.35 (17.87) | (−36.15 to −1.35) |
| Effectiveness | ||||||
| QALYs | 0.0120 (0.0169) | (−0.0211 to 0.0451) | 0.0108 (0.0182) | (−0.0250 to 0.0467) | −0.0012 (0.0248) | (−0.0500 to 0.0474) |
| Epworth | 5.079 (0.5323) | (4.034 to 6.124) | 3.932 (0.5381) | (2.869 to 4.992) | −1.147 (0.7552) | (−2.643 to 0.3317) |
| CPAP use (h) | 4.179 (0.2752) | (3.633 to 4.717) | 4.416 (0.2583) | (3.911 to 4.922) | 0.2377 (0.377) | (−0.5009 to 0.9699) |
*Mean and SD for time variables. For other variables, number of cases and % of the sample that used this resource.
CPAP, continuous positive airway pressure; QALYs, quality-adjusted life years; SAHS, sleep apnoea-hypopnoea syndrome.